Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord-derived mesenchymal stem cells (Trustem)
- Development stage
- Unknown
- Lead developer
- TruStem Cell Therapy
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Umbilical cord-derived mesenchymal stem cells (UC-MSCs) developed by Trustem are an allogeneic cell therapy being evaluated for the treatment of severe COVID-19. These cells possess potent immunomodulatory and anti-inflammatory properties, which are hypothesized to mitigate the systemic hyperinflammation, often referred to as a cytokine storm, and acute respiratory distress syndrome (ARDS) associated with severe SARS-CoV-2 infection. By secreting various paracrine factors and interacting directly with immune cells, UC-MSCs can modulate the activity of T-cells, B-cells, and macrophages, promoting a transition from a pro-inflammatory to an anti-inflammatory environment and supporting lung tissue repair. The therapy is administered via intravenous infusion to provide systemic immunomodulation.
- Other names
- UC-MSCsUmbilical cord mesenchymal stem cellsCELMA
Beyond the preview
Go deeper on umbilical cord-derived mesenchymal stem cells (Trustem).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (Trustem).